• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对行皮输尿管造口术患者进行症状性尿路感染和无症状菌尿的筛查生物标志物和预测模型的构建:一项宏基因组下一代测序研究。

Screening Biomarkers and Constructing a Predictive Model for Symptomatic Urinary Tract Infection and Asymptomatic Bacteriuria in Patients Undergoing Cutaneous Ureterostomy: A Metagenomic Next-Generation Sequencing Study.

机构信息

Department of Nursing, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.

Nursing School, Nanchang University, Nanchang 330006, China.

出版信息

Dis Markers. 2022 Apr 28;2022:7056517. doi: 10.1155/2022/7056517. eCollection 2022.

DOI:10.1155/2022/7056517
PMID:35531475
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9072028/
Abstract

OBJECTIVES

To investigate the clinical diagnostic value of differential flora as biomarkers in patients with symptomatic urinary tract infection (UTI) and asymptomatic bacteriuria (ASB) undergoing cutaneous ureterostomy based on metagenomic next-generation sequencing and construct predictive models to provide a scientific reference for clinical diagnosis and treatment. . According to standard procedures, samples were taken from each patient for routine tests (urine, ureteral stent, and skin swab around the stoma). Cytokine levels in the blood were also detected. Urinary microflora were measured by mNGS, and potential biomarkers for distinguishing UTI and ASB were identified by differential flora. Finally, we generated the predictive models for ASB and UTI using the Lasso method and cytokine levels.

RESULTS

Urine culture was performed for 50 patients with cutaneous ureterostomy; 44 of these patients developed bacteriuria. The incidence of symptomatic bacteriuria was 54.55%. Biomarker analysis showed that , , , , and all had good predictive performance and were combined in a single model. The predictive model exhibited good prediction performance (area under the curve (AUC) = 0.8729, sensitivity = 80%, specificity = 83.3%, and cutoff = 1.855). We also identified a significant negative correlation between the weight sum of the abundance for these five characteristic pathogens (Sum_weighted_Reads) and levels of the cytokine IL-6 and IL-1 ( < 0.05).

CONCLUSION

mNGS had a higher positive detection rate for pathogens in urine samples. The selected differential bacteria can be used as biomarkers of ASB and UTI, and the prediction model has good predictive performance. Analysis also showed that the occurrence of symptoms was related to individual immunity. Combined with the Sum_weighted_Reads cutoff and cytokine levels (IL-6 and IL-1) of differential flora, it was possible to judge the severity of symptoms in cutaneous ureterostomy patients with bacteriuria and provide new insights for the treatment and intervention of ASB and UTI.

摘要

目的

基于宏基因组下一代测序技术,探讨基于宏基因组下一代测序技术的差异菌群作为生物标志物在接受皮输尿管造口术的有症状尿路感染(UTI)和无症状菌尿(ASB)患者中的临床诊断价值,并构建预测模型,为临床诊治提供科学参考。按照标准程序,从每位患者身上采集样本进行常规检查(尿液、输尿管支架和造口周围皮肤拭子),并检测血液中的细胞因子水平。通过 mNGS 测量尿液微生物群,通过差异菌群鉴定区分 UTI 和 ASB 的潜在生物标志物。最后,我们使用 Lasso 方法和细胞因子水平生成 ASB 和 UTI 的预测模型。

结果

对 50 例皮输尿管造口术患者进行尿液培养,其中 44 例患者发生菌尿,症状性菌尿发生率为 54.55%。生物标志物分析表明, 、 、 、 和 均具有良好的预测性能,并组合成一个单一模型。该预测模型具有良好的预测性能(曲线下面积(AUC)=0.8729,灵敏度=80%,特异性=83.3%,截断值=1.855)。我们还发现,这五种特征病原体丰度的加权总和(Sum_weighted_Reads)与细胞因子 IL-6 和 IL-1 的水平之间存在显著负相关( < 0.05)。

结论

mNGS 对尿液样本中病原体的阳性检出率较高。所选差异细菌可作为 ASB 和 UTI 的生物标志物,预测模型具有良好的预测性能。分析还表明,症状的发生与个体免疫有关。结合 Sum_weighted_Reads 截断值和差异菌群的细胞因子(IL-6 和 IL-1)水平,有可能判断皮输尿管造口术患者菌尿的症状严重程度,为 ASB 和 UTI 的治疗和干预提供新的思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d51/9072028/bc0d14f76992/DM2022-7056517.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d51/9072028/f5b1e9be8949/DM2022-7056517.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d51/9072028/a09b6985d3f7/DM2022-7056517.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d51/9072028/95fdc72edb67/DM2022-7056517.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d51/9072028/d1d27f5f5e09/DM2022-7056517.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d51/9072028/dd704a925b39/DM2022-7056517.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d51/9072028/d6aa646f4ec7/DM2022-7056517.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d51/9072028/bc0d14f76992/DM2022-7056517.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d51/9072028/f5b1e9be8949/DM2022-7056517.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d51/9072028/a09b6985d3f7/DM2022-7056517.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d51/9072028/95fdc72edb67/DM2022-7056517.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d51/9072028/d1d27f5f5e09/DM2022-7056517.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d51/9072028/dd704a925b39/DM2022-7056517.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d51/9072028/d6aa646f4ec7/DM2022-7056517.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d51/9072028/bc0d14f76992/DM2022-7056517.007.jpg

相似文献

1
Screening Biomarkers and Constructing a Predictive Model for Symptomatic Urinary Tract Infection and Asymptomatic Bacteriuria in Patients Undergoing Cutaneous Ureterostomy: A Metagenomic Next-Generation Sequencing Study.对行皮输尿管造口术患者进行症状性尿路感染和无症状菌尿的筛查生物标志物和预测模型的构建:一项宏基因组下一代测序研究。
Dis Markers. 2022 Apr 28;2022:7056517. doi: 10.1155/2022/7056517. eCollection 2022.
2
Application of metagenomic next-generation sequencing in the diagnosis of urinary tract infection in patients undergoing cutaneous ureterostomy.宏基因组下一代测序在皮输尿管造口术患者尿路感染诊断中的应用。
Front Cell Infect Microbiol. 2023 Jan 27;13:991011. doi: 10.3389/fcimb.2023.991011. eCollection 2023.
3
Asymptomatic bacteriuria is an independent predictor of urinary tract infections in an ambulatory cirrhotic population: a prospective evaluation.无症状菌尿是门诊肝硬化患者尿路感染的独立预测因素:一项前瞻性评估。
Liver Int. 2014 Jul;34(6):e39-44. doi: 10.1111/liv.12435. Epub 2014 Jan 7.
4
Diagnostic accuracy of urine biomarkers for urinary tract infection in older women: a case-control study.诊断老年女性尿路感染尿液生物标志物的准确性:病例对照研究。
Clin Microbiol Infect. 2024 Feb;30(2):216-222. doi: 10.1016/j.cmi.2023.09.023. Epub 2023 Oct 5.
5
Urine biomarkers individually and as a consensus model show high sensitivity and specificity for detecting UTIs.尿液生物标志物单独或作为共识模型,对检测尿路感染具有较高的灵敏度和特异性。
BMC Infect Dis. 2024 Jan 31;24(1):153. doi: 10.1186/s12879-024-09044-2.
6
Distinguishing asymptomatic bacteriuria from urinary tract infection in the elderly - the use of urine levels of heparin-binding protein and interleukin-6.区分老年人无症状菌尿与尿路感染——肝素结合蛋白和白细胞介素-6尿液水平的应用
Diagn Microbiol Infect Dis. 2016 Jun;85(2):243-8. doi: 10.1016/j.diagmicrobio.2016.03.005. Epub 2016 Mar 2.
7
Similar Neutrophil-Driven Inflammatory and Antibacterial Responses in Elderly Patients with Symptomatic and Asymptomatic Bacteriuria.有症状和无症状菌尿老年患者中类似的中性粒细胞驱动的炎症和抗菌反应
Infect Immun. 2015 Oct;83(10):4142-53. doi: 10.1128/IAI.00745-15. Epub 2015 Aug 3.
8
Differentiating Asymptomatic Bacteriuria From Urinary Tract Infection in the Pediatric Neurogenic Bladder Population: NGAL As a Promising Biomarker.区分小儿神经源性膀胱人群中的无症状菌尿与尿路感染:中性粒细胞明胶酶相关脂质运载蛋白作为一种有前景的生物标志物
Top Spinal Cord Inj Rehabil. 2019 Summer;25(3):214-221. doi: 10.1310/sci2503-214.
9
Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis.预测无症状菌尿女性复发性症状性尿路感染接受预防治疗时引起感染的大肠埃希菌药敏的价值。
Clin Microbiol Infect. 2012 Apr;18(4):E84-90. doi: 10.1111/j.1469-0691.2012.03773.x. Epub 2012 Feb 13.
10
Triggered Urine Interleukin-6 Correlates to Severity of Symptoms in Nonfebrile Lower Urinary Tract Infections.非发热性下尿路感染症状严重程度与尿白细胞介素-6 呈相关性。
J Urol. 2017 Jul;198(1):107-115. doi: 10.1016/j.juro.2017.01.070. Epub 2017 Feb 1.

引用本文的文献

1
Comparison Shows that Multiplex Polymerase Chain Reaction Identifies Infection-associated Urinary Biomarker-positive Urinary Tract Infections That Are Missed by Standard Urine Culture.比较表明,多重聚合酶链反应可识别标准尿培养漏诊的感染相关尿生物标志物阳性的尿路感染。
Eur Urol Open Sci. 2023 Nov 9;58:73-81. doi: 10.1016/j.euros.2023.10.008. eCollection 2023 Dec.
2
Elevated UTI Biomarkers in Symptomatic Patients with Urine Microbial Densities of 10,000 CFU/mL Indicate a Lower Threshold for Diagnosing UTIs.尿液微生物密度为10,000 CFU/mL的有症状患者中,尿路感染生物标志物升高表明诊断尿路感染的阈值较低。
Diagnostics (Basel). 2023 Aug 16;13(16):2688. doi: 10.3390/diagnostics13162688.

本文引用的文献

1
Transcriptomic analyses and experimental verification reveal potential biomarkers and biological pathways of urinary tract infection.转录组分析和实验验证揭示了尿路感染的潜在生物标志物和生物学途径。
Bioengineered. 2021 Dec;12(1):8529-8539. doi: 10.1080/21655979.2021.1987081.
2
Clinical Evaluation of an Improved Metagenomic Next-Generation Sequencing Test for the Diagnosis of Bloodstream Infections.一种改进的宏基因组下一代测序检测用于血流感染诊断的临床评估
Clin Chem. 2021 Aug 5;67(8):1133-1143. doi: 10.1093/clinchem/hvab061.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
Urinary tract infection as the main cause of admission in cystectomized patients.尿路感染是膀胱切除患者入院的主要原因。
Actas Urol Esp (Engl Ed). 2021 May;45(4):247-256. doi: 10.1016/j.acuro.2020.10.001. Epub 2021 Jan 28.
5
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines.欧洲泌尿外科学会肌层浸润性和转移性膀胱癌指南:2020 年指南摘要。
Eur Urol. 2021 Jan;79(1):82-104. doi: 10.1016/j.eururo.2020.03.055. Epub 2020 Apr 29.
6
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.膀胱癌临床实践指南(第 3 版). 2020 年 NCCN 版
J Natl Compr Canc Netw. 2020 Mar;18(3):329-354. doi: 10.6004/jnccn.2020.0011.
7
Usefulness of next-generation DNA sequencing for the diagnosis of urinary tract infection.新一代DNA测序在尿路感染诊断中的应用价值
Drug Discov Ther. 2020 Mar 8;14(1):42-49. doi: 10.5582/ddt.2020.01000. Epub 2020 Feb 27.
8
A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors.IL-6:结构、病理生理作用及抑制剂全景综述。
Bioorg Med Chem. 2020 Mar 1;28(5):115327. doi: 10.1016/j.bmc.2020.115327. Epub 2020 Jan 20.
9
Urinary tract infections following radical cystectomy with enhanced recovery protocol: A prospective study.根治性膀胱切除术联合加速康复方案后发生的下尿路感染:一项前瞻性研究。
Urol Oncol. 2020 Mar;38(3):75.e9-75.e14. doi: 10.1016/j.urolonc.2019.12.021. Epub 2020 Jan 16.
10
Screening for Asymptomatic Bacteriuria in Adults: US Preventive Services Task Force Recommendation Statement.成人无症状菌尿筛查:美国预防服务工作组推荐声明。
JAMA. 2019 Sep 24;322(12):1188-1194. doi: 10.1001/jama.2019.13069.